Literature DB >> 16091452

Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL).

Renato Zambello1, Tamara Berno, Giovanna Cannas, Ilenia Baesso, Gianni Binotto, Emanuela Bonoldi, Pierantonio Bevilacqua, Marta Miorin, Monica Facco, Livio Trentin, Carlo Agostini, Gianpietro Semenzato.   

Abstract

We investigated whether dendritic cells (DCs) play a role in favoring granular lymphocyte (GL) proliferation in patients with lymphoproliferative disease of granular lymphocytes (LDGL). The presence of in vivo circulating DCs was studied in 11 patients (5 CD3+ and 6 CD3- LDGL). Autologous immature (iDCs) and mature (mDCs) DCs generated in vitro were studied for stimulatory activity on cell proliferation of CD3+ and CD3- GLs. The topographic organization of GLs and DCs was also studied in bone marrow (BM) biopsies. Peripheral blood (PB) CD3- GLs from patients showed significant proliferative activity in the presence of iDCs and mDCs. Conversely, monoclonal CD3+ GLs were unresponsive to autologous and allogeneic PB DCs. Analysis of BM biopsies demonstrated a topographic distribution of DCs and GLs that indicates contact between the 2 cell types. On functional assays, DCs obtained from BM were more efficient than PB DCs in stimulating CD3- GLs, and surprisingly, a low but definite stimulatory effect was demonstrated also on CD3+ GLs. The putative contact between DCs and GLs in the BM and, more crucial, the proliferative response of discrete GL populations to DC stimulation suggest the presence of a specific antigen within BM DCs, providing evidence for a role of DCs in the pathogenesis of LDGL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091452     DOI: 10.1182/blood-2005-05-1972

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Large granular lymphocyte disorders: new etiopathogenetic clues as a rationale for innovative therapeutic approaches.

Authors:  Renato Zambello; Gianpietro Semenzato
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 2.  All that glitters is not LGL Leukemia.

Authors:  Gianpietro Semenzato; Antonella Teramo; Giulia Calabretto; Vanessa Rebecca Gasparini; Renato Zambello
Journal:  Leukemia       Date:  2022-09-15       Impact factor: 12.883

Review 3.  Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.

Authors:  Nina Couette; Wael Jarjour; Jonathan E Brammer; Alexa Simon Meara
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

4.  CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk.

Authors:  Constance Baer; Shunsuke Kimura; Mitra S Rana; Andrew B Kleist; Tim Flerlage; David J Feith; Peter Chockley; Wencke Walter; Manja Meggendorfer; Thomas L Olson; HeeJin Cheon; Kristine C Olson; Aakrosh Ratan; Martha-Lena Mueller; James M Foran; Laura J Janke; Chunxu Qu; Shaina N Porter; Shondra M Pruett-Miller; Ravi C Kalathur; Claudia Haferlach; Wolfgang Kern; Elisabeth Paietta; Paul G Thomas; M Madan Babu; Thomas P Loughran; Ilaria Iacobucci; Torsten Haferlach; Charles G Mullighan
Journal:  Nat Genet       Date:  2022-05-05       Impact factor: 41.307

5.  Close resemblance between chemokine receptor expression profiles of lymphoproliferative disease of granular lymphocytes and their normal counterparts in association with elevated serum concentrations of IP-10 and MIG.

Authors:  Kayoko Momose; Hideki Makishima; Toshiro Ito; Hideyuki Nakazawa; Shigetaka Shimodaira; Kendo Kiyosawa; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 6.  Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction?

Authors:  Renato Zambello; Antonella Teramo; Gregorio Barilà; Cristina Gattazzo; Gianpietro Semenzato
Journal:  Front Immunol       Date:  2014-02-26       Impact factor: 7.561

7.  Retrovirus insertion site analysis of LGL leukemia patient genomes.

Authors:  Weiling Li; Lei Yang; Robert S Harris; Lin Lin; Thomas L Olson; Cait E Hamele; David J Feith; Thomas P Loughran; Mary Poss
Journal:  BMC Med Genomics       Date:  2019-06-17       Impact factor: 3.063

8.  Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?

Authors:  Edoardo Giussani; Andrea Binatti; Giulia Calabretto; Vanessa Rebecca Gasparini; Antonella Teramo; Cristina Vicenzetto; Gregorio Barilà; Monica Facco; Alessandro Coppe; Gianpietro Semenzato; Stefania Bortoluzzi; Renato Zambello
Journal:  Front Oncol       Date:  2021-01-18       Impact factor: 6.244

Review 9.  Neutropenia and Large Granular Lymphocyte Leukemia: From Pathogenesis to Therapeutic Options.

Authors:  Giulia Calabretto; Antonella Teramo; Gregorio Barilà; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Gianpietro Semenzato; Renato Zambello
Journal:  Cells       Date:  2021-10-19       Impact factor: 6.600

10.  Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases?

Authors:  Renato Zambello; Antonella Teramo; Cristina Gattazzo; Gianpietro Semenzato
Journal:  Transl Med UniSa       Date:  2014-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.